In context
Hexapeptide-9 was studied in a topical delivery system combining an ionic liquid with the peptide. The programme included laboratory, animal and human cosmetic assessments. [1]
At a glance
- Type
- Topical cosmetic ingredient
- Regulatory context
- The cited source describes research, not a determination of present marketing authorisation. Country, formulation and indication must be checked separately.
- Evidence
- The delivery system and peptide were studied together. Results do not establish the same outcome for other formulations or prove that an endogenous ingredient is risk-free.
How to interpret this evidence
The delivery system and peptide were studied together. Results do not establish the same outcome for other formulations or prove that an endogenous ingredient is risk-free. [1]
Safety and clinical context
Topical cosmetic research does not support injection or other systemic use. Safety and tolerability depend on the complete formulation and the person using it.
Evidence and authorisation depend on the product, formulation, indication and country. US labelling does not establish Thai authorisation. This guide is educational and is not a dosing or self-treatment protocol.
Primary sources
Read the underlying source and its limitations. A study citation does not by itself establish efficacy or approval.